TERT and neoplasm: A study using whole genome sequence analysis of 2658 genomes [151,152] and their matching normal tissues across 38 tumor types (of these, 2583 were considered high-quality samples) demonstrated that driver mutations in the TERT promoter were by far the most frequent of noncoding mutations as well as the most frequent across different tumor types (14 cohorts out of 38) [152].